Cipla Ltd.
NSE: CIPLA | BSE: 500087
₹1,377.00
₹0.50
(0.04%)
As on 10-Jun-2026IST
Market cap
₹1,11,487 Cr
Revenue (TTM)
₹28,163 Cr
P/E Ratio
28.7
P/B Ratio
3.2
Div. Yield
0.9 %
Quality Score
8/10
Growth Score
5/10
Valuation Score
5/10
Momentum Score
4/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹3,870 Cr
-
ROE
11.8 %
-
ROCE
16 %
-
Industry P/E
35.05
-
EV/EBITDA
16.3
-
Debt to Equity
0
-
Book Value
₹425.5
-
EPS
₹48
-
Face value
2
-
Shares outstanding
807,845,316
10 Years Aggregate
CFO
₹32,001.77 Cr
EBITDA
₹44,627.98 Cr
Net Profit
₹26,630.76 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Cipla
| -8.9 | 2.2 | 3.9 | -8.6 | 12.4 | 7.5 | 11.1 |
|
BSE Sensex
| -12.6 | -4.3 | -4.6 | -10.3 | 5.7 | 7.3 | 10.7 |
|
BSE Healthcare
| 8.2 | 1.0 | 8.3 | 8.0 | 24.8 | 13.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Cipla
| -1.2 | 22.2 | 15.8 | 14.0 | 14.2 | 72.3 | -8.6 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Cipla
|
1,377.0 | 1,11,486.7 | 28,162.6 | 3,869.8 | 16.6 | 11.8 | 28.7 | 3.2 |
| 5,299.5 | 63,489.0 | 14,712.3 | 2,353.1 | 17.8 | 17.7 | 27.6 | 4.6 | |
| 1,453.6 | 83,544.9 | 33,653.1 | 3,501.5 | 14.9 | 9.7 | 23.8 | 2.2 | |
| 414.6 | 67,332.5 | 16,927.0 | 368.8 | 8.8 | -0.6 | 174.6 | 2.0 | |
| 1,271.7 | 1,06,094.8 | 33,700.2 | 4,144.2 | 13.0 | 11.4 | 25.3 | 2.8 | |
| 2,247.2 | 1,02,977.9 | 27,958.0 | 5,355.5 | 26.6 | 27.4 | 19.3 | 4.6 | |
| 2,376.2 | 98,640.0 | 14,277.6 | 1,926.4 | 19.1 | 12.8 | 51.6 | 6.1 | |
| 1,786.4 | 4,29,049.1 | 58,462.0 | 11,564.5 | 23.9 | 15.4 | 37.4 | 5.1 | |
| 4,463.7 | 1,51,285.1 | 13,979.7 | 2,138.2 | 24.6 | 26.8 | 69.9 | 18.0 | |
| 1,098.3 | 1,10,484.5 | 27,148.4 | 5,026.4 | 21.9 | 20.7 | 21.9 | 4.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Mohammed Ekramul Haque
Challenge the equity-return assumption
6 min read•By Aarati Krishnan
FIIs Vs DIIs: Different strokes
3 min read•By Kumar Shankar Roy
2 min read•By Mohammed Ekramul Haque
2 min read•By Mohammed Ekramul Haque and Vikas Vardhan
Five stocks poised for take-off
1 min read•By Mohammed Ekramul Haque and Vikas Vardhan
About Cipla
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures... segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India. Read more
-
Incorporated
1935
-
Chairman
Y K Hamied
-
Managing Director
Achin Gupta
-
Group
Cipla
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Cipla
What is the current share price of Cipla Ltd Today?
The share price of Cipla Ltd is ₹1,377.00 (NSE) and ₹1,376.25 (BSE) as of 10-Jun-2026 IST. Cipla Ltd has given a return of 12.42% in the last 3 years.
What is the current PB & PE ratio of Cipla Ltd?
The P/E ratio of Cipla Ltd is 28.74 times as on 10-Jun-2026, a 18 discount to its peers’ median range of 35.05 times.
The P/B ratio of Cipla Ltd is 3.24 times as on 10-Jun-2026, a 34 discount to its peers’ median range of 4.93 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
25.47
|
2.87
|
|
2025
|
22.08
|
3.75
|
|
2024
|
29.28
|
4.53
|
|
2023
|
25.95
|
3.11
|
|
2022
|
32.65
|
3.95
|
What is the 52 Week High and Low of Cipla Ltd?
The 52-week high and low of Cipla Ltd are Rs 1,673.00 and Rs 1,165.70 as of 10-Jun-2026.
What is the market cap of Cipla Ltd?
Cipla Ltd has a market capitalisation of ₹ 1,11,487 Cr as on 10-Jun-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in Cipla Ltd?
Before investing in Cipla Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.